19 June 2013
Keywords: lilly/alkermes, begin, phiii, insulin, study, usa-based, firms
Article | 08 May 2006
USA-based firms Eli Lilly and Alkermes say they have begun a Phase III registration trial for their co-developed AIR inhaled ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 May 2006
24 April 2006
15 May 2006
© 2013 thepharmaletter.com